Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
4
Bearish filings
69
Named actors
16
Disclosed $ (bull / bear)
$41K + 2 of unknown size / $19.3M + 10 of unknown size
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-10-02 | EVP, CLO, Alkermes, Inc. Gaffin David Joseph | sold | $83K | SEC ↗ |
| 2026-10-02 | Officer (via Merrill Lynch) Gaffin David Joseph | filed notice to sell | $83K | SEC ↗ |
| 2026-09-29 | Congress Gilbert Cisneros | bought | $8K | — |
| 2026-09-03 | EVP, CLO, Alkermes, Inc. Gaffin David Joseph | sold | $98K | SEC ↗ |
| 2026-09-03 | Officer (via Merrill Lynch) Gaffin David Joseph | filed notice to sell | $98K | SEC ↗ |
48 more disclosures in the window — the full record, scoring, and track-record evidence are for members.
Want the read, not just the record?
Members see how notable each move is, the actor's past track record, cross-source convergence, and alerts on this name.
Start free — 1 week, no card →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals
| 2026-09-01 |
| EVP R&D, Chief Medical Officer Hopkinson Craig C. |
| sold |
| $423K |
| SEC ↗ |
| 2026-09-01 | Officer (via Merrill Lynch) Hopkinson Craig C. | filed notice to sell | $423K | SEC ↗ |
| 2026-08-17 | SVP, Chief Commercial Officer Nichols Christian Todd | sold | $340K | SEC ↗ |
| 2026-08-17 | SVP, Chief Commercial Officer Nichols Christian Todd | sold | $33K | SEC ↗ |
| 2026-08-17 | Officer (via Merrill Lynch) Nichols Christian Todd | filed notice to sell | $373K | SEC ↗ |
| 2026-08-03 | EVP, CLO, Alkermes, Inc. Gaffin David Joseph | sold | $99K | SEC ↗ |
| 2026-08-03 | EVP R&D, Chief Medical Officer Hopkinson Craig C. | sold | $437K | SEC ↗ |
| 2026-08-03 | Director snyderman nancy lynn MD | sold | $2.2M | SEC ↗ |
| 2026-08-03 | Officer (via Merrill Lynch) Hopkinson Craig C. | filed notice to sell | $437K | SEC ↗ |
| 2026-08-03 | Officer (via Merrill Lynch) Gaffin David Joseph | filed notice to sell | $99K | SEC ↗ |
| 2026-08-03 | Officer (via Merrill Lynch) snyderman nancy lynn MD | filed notice to sell | $2.2M | SEC ↗ |
| 2026-07-30 | Congress Gilbert Cisneros | bought | $33K | — |
| 2026-07-06 | EVP, CLO, Alkermes, Inc. Gaffin David Joseph | sold | $110K | SEC ↗ |
| 2026-07-06 | Officer (via Merrill Lynch) Gaffin David Joseph | filed notice to sell | $110K | SEC ↗ |
| 2026-07-01 | EVP R&D, Chief Medical Officer Hopkinson Craig C. | sold | $427K | SEC ↗ |
| 2026-07-01 | EVP R&D, Chief Medical Officer Hopkinson Craig C. | sold | $36K | SEC ↗ |
| 2026-07-01 | Officer (via Merrill Lynch) Hopkinson Craig C. | filed notice to sell | $464K | SEC ↗ |
| 2026-06-12 | Chief Operating Officer Blair Jackson | adopted a selling plan | — | SEC ↗ |
| 2026-06-12 | Director Wright Christopher I | sold | $90K | SEC ↗ |
| 2026-06-12 | Officer (via Merrill Lynch) Wright Christopher I | filed notice to sell | $90K | SEC ↗ |